# Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis

> **NCT00681551** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 45 (actual)

## Conditions studied

- Brain Neoplasms

## Interventions

- **DRUG:** Magnevist (SH L 451A)
- **DRUG:** Magnevist (SH L 451A)

## Key facts

- **NCT ID:** NCT00681551
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** 2004-03
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2014-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00681551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00681551, "Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00681551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*